Methods for treatment of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
AssigneeBerg LLC
InventorsNiven Rajin Narain, John Patrick McCook, Rangaprasad Sarangarajan
Life of this patent
Estimating the term…
Abstract
Methods and formulations for treating oncological disorders in humans using epimetabolic shifters, multidimensional intracellular molecules or environmental influencers are described.
Claims23
A method for treating an oncological disorder in a mammal having the oncological disorder, consisting of administering to the mammal a therapeutically effective amount of a composition consisting of 0.001% to 30% w/w of Coenzyme Q10 and one or more pharmaceutically acceptable carriers, wherein the Coenzyme Q10 is in the oxidized form and has a purity between 95% and 100%, thereby treating the oncological disorder, wherein the oncological disorder is not melanoma.
A method for blocking anaerobic use of glucose (glycolysis) or augmenting mitochondrial oxidative phosphorylation in a cancer cell, the method consisting of:
- exposing said cancer cell to a therapeutically effective amount of a composition consisting of 0.001% to 30% w/w of Coenzyme Q10 and one or more pharmaceutically acceptable carriers, wherein the Coenzyme Q10 is supplied in the oxidized form and has a purity between 95% and 100%, to thereby block anaerobic use of glucose or to augment mitochondrial oxidative phosphorylation in said cancer cell, wherein the cancer cell is not a melanoma cell.
Dependencies are inferred from the claim text.